Antenatal Care Flashcards
Risk of miscarriage following Amnio or CVS for:
1. Singleton
2. Twin
- Singleton - 0.5%
- Twin 1%
When is:
1. CVS performed?
2. Amnio performed?
- CVS 11+0 - 13+6
- Amnio from 15+0
Risks associated with Amnio?
- Second sample/rpt procedure - 6%
- Blood stained sample - 0.8%
- Maternal cell contamination - 1-2%
- Rapid test failure - 2%
- Failed cell culture - 0.5-1%
- Severe infection/fetal injury / maternal visceral injury - rare
Risks associated with CVS?
- Second sample/rpt procedure - 6%
- Confined placental mosaicism - <2%
- Maternal cell contamination - 1-2%
- Rapid test failure - 2%
- Failed cell culture - 0.5-1%
- Severe infection / fetal injury / maternal visceral injury - rare
Chickenpox:
1. Incubation period?
2. Infectious period?
- Incubation period: 1-3 weeks
- Infectious period: 48 hours before the rash appears and continues to be infectious until vesicles crust over (usually 5 days)
Treatment of chickenpox in Pregnancy?
- If non immune pregnant woman has significant exposure, she should be offered VZIG as soon as possible (effective when given up to 10 days after contact).
- Oral Aciclovir should be given:
- Within 24 hours of onset of rash
- If over 20/40
- IV Aciclovir should be given to women with severe chickenpox
If maternal chicken pox happened in last 4 weeks of pregnancy:
1. What is the plan for delivery?
2. % of babies infected?
3. % of babies that develop clinical varicella?
- Avoid planned delivery for 7 days to allow for passive transfer of antibodies
- 50% of babies are infected
- Approx 23% will develop clinical varicella
For babies born to mothers who have had chickenpox within the period 7 days before to 7 days after delivery - the neonate will need VZIG with or without Aciclovir ASAP.
No need to test neonate in these circumstances.
Chickenpox infection < 28/40 management?
- 1% chance of FVS
- Refer to FMU at 16-20 weeks or 5 weeks after infection
- Amniocentesis to detect varicella DNA may be considered
What are the three subgroups of neonatal herpes?
What is the mortality and morbidity of each subgroup?
- Disease localised to skin/eye/mouth
- 30% of neonatal herpes infections
- <2% morbidity with appropriate Rx - Local CNS disease (encephalitis)
- 70% of infections
- 6% mortality
- 70% neurological abnormality - Disseminated infection with multi organ involvement
- 70% infections combined with local CNS disease
- 30% mortality from disseminated infection
- 17% long term neurological sequelae
60% will present without skin/eye/mouth infection.
Present late - typically 10 days to 4 weeks
Neonatal Herpes:
1. HSV 1
2. HSV 2
HSV 1: 50%
HSV 2: 50%
TTTS complicates what % of Monochorionic Pregnancies?
15%
Incidence if TAPS (twin anaemia-polycythaemia sequence) after laser ablation?
13%
(2% uncomplicated monochorionic twins)
TTTS (Quintero Staging)
Associated with 15% Monochorionic Twins.
I - significant discordance in amniotic fluid volume. This is defined as: oligo with DVP < 2cm in donor sac and Poly in the recipient sac (DVP > 8cm before 20/40 and >10cm after 20/40). Donor bladder visible and normal Doppler.
II - Bladder of the donor twin not visible and severe oligo due to anuria. Doppler studies not critically abnormal.
III - Doppler studies are critically abnormal in either the donor or recipient.
IV - Ascites, pericardial effusion, scalp oedema or overt hydrops present usually in the recipient.
V - One or both babies have died (not amenable to therapy)
TAPS (twin anaemia- polycythaemia sequence)
1. Incidence
2. Definition
2% uncomplicated Monochorionic pregnancies
Up to 13% post laser ablation
Signs of fetal anaemia in the donor and polycythaemia in the recipient without significant oligo/poly being present.
Donor has increased MCA PSV (> 1.5 MoM) and recipient has decreased MCA PSV (< 1.0 MoM)
Selective Growth Restriction Monochorionic Twins
- Incidence
- Define
- Growth discordance > 20%
- Approx 10-15% monochorionic twins
I - growth discordance but positive diastolic velocities in both fetal and umbilical arteries.
II - Growth discordance with absent or reversed end diastolic velocities in one or both fetuses.
III - growth discordance with cyclical UA diastolic waveforms (iAREDV)
Risk of congenital CMV with primary infection during Pregnancy?
30-40%
Risk of congenital infection with recurrent CMV?
1-2%
Risk of congenital infection with recurrent CMV?
1-2%
Incubation period for CMV?
3-12 weeks
Diagnosis of fetal CMV is by Amniocentesis.
Amnio should not be performed for at least 6 weeks after maternal infection and not until 21/40.
List features of congenital CMV
- Sensorineural hearing loss
- Visual impairment
- Microcephaly
- Low birth weight
- Seizures
- Cerebral palsy
- Hepatosplenomegaly with jaundice
- Thrombocytopenia with petechial rash
In women who develop chickenpox within the 4 weeks prior to delivery, what is the risk of varicella infection of the newborn?
50% of babies are infected.
23% of babies develop clinical varicella.
High risk factors for antenatal Aspirin?
Moderate risk factors for antenatal Aspirin?
High Risk Factors:
1. Hypertensive disease during a previous pregnancy
2. CKD
3. Autoimmune disease such as SLE or APLS
4. Type 1 or Type 2 DM
5. Chronic HTN
Moderate Risk Factor:
1. Primip
2. Age > 40
3. Inter pregnancy interval > 10 years
4. BMI > 35
5. FHx PET
6. Multiple Pregnancy
Risk of renal transplant injury at LSCS?
1.5%
Consider midline skin incision to reduce risk of trauma to allograft.
Risk of cephalhaematoma with vacuum?
1-12%
Risk of facial or scalp lacerations with instrumental delivery? (Vacuum and Forceps)
10%
Risk of retinal haemorrhage with instrumental delivery?
17-38%
Monochorionic twin pregnancy with single twin demise.
1. Risks?
2. Investigations?
- Neurological abnormality 26%
Death 15% - Fetal MRI of brain 4/52 after co-twin demise
MCMA twins comprise what % of monochorionic twin pregnancies?
1%
They carry a very high risk of perinatal loss, most commonly before 24/40.
Selective growth restriction in monochorionic twin pregnancies.
- % cases
- Staging
Growth discordance of > 20%.
Approx 10-15% monochorionic twins.
Staging:
I - growth discordance but +ve EDF in both fetal UA.
II - growth discordance with absent or reversed EDF in one or both fetuses.
III - growth discordance with cyclical UA diastolic waveforms (+ve followed by absent then reversed EDF in a cyclical pattern over several minutes).
Lambda and T sign
- Monochorionic - T sign (inter twin membrane that inserts into the placenta at a perpendicular plane)
- Dichorionic - lambda sign (adjacent pelvic masses forming a lambda sign as placental tissue is present where the thick inter twin membrane inserts onto the placenta)
Recurrence rate of TTTS following fetoscopic laser ablation?
Up to 14%
Likely due to missed anastamoses at the time of initial laser treatment.
% of women that are GBS carriers?
20-40%
Incidence of early onset GBS?
0.57/1000
Of these:
1. 22% born prematurely
- 35% had 1 or more of the following RFs (prev baby affected by GBS, GBS bacteruria, vaginal swab pos for GBS or mat T > 38C in labour)
Intrapartum pyrexia and risk of EOGBS?
5.3/1000
(Compared to background risk of 0.6/1000)
Risk of EOGBS in preterm infants?
What % of women deliver pre term?
- 2.3/1000
(Mortality rate from infection is increased at preterm gestation (20-30% vs 2-3% at term)
- 8.2%
Incidence of EOGBS without risk factors?
0.2/1000 cases.
Main reason for transfer to an obstetric unit from home/birth unit?
- Delay in 1st or 2nd stage
(32% from home, 37% birth unit) - Meconium
(12.2% from home/Birth unit)
IOL for fetal macrosomia vs expectant management
Benefit:
1. Lower rates of SD vs expectant management
Risks:
2. Increased 3rd/4th degree tears
Same:
1. Perinatal death
2. Brachial plexus injury
3. Need for EmLSCS
Low risk primip wanting home birth - risks of babies born with serious medical problems vs hospital/MLU?
Home: 9/1000
Hosp/MLU: 5/1000
75%: Neonatal encephalopathy and Meconium aspiration syndrome
13%: Intrapartum SB or death of baby in first week of life
4%: # humerus/clavicle
Pre-Labour Rupture of Membranes:
1. Risk of infection
2. Chance of spont labour within 24h
- Risk of serious neonatal infection 1% rather than 0.5% for women with intact membranes
- 60% of women with pre labour rupture of membranes will go into labour within 24 hours
Maternal cardiac arrest.
1. Incidence
2. Case fatality rate
3. Leading cause
- 1/36,000
- 42% case fatality rate
- 25% secondary to anaesthesia (100% survival from this)
Amniotic Fluid Embolism:
1. Incidence
2. Survival
3. Perinatal Mortality
- Incidence: 1.7/100,000
- 81% survival (2014)
- Perinatal mortality: 67/1000 births
MOH Incidence?
6/1000
Anaphylaxis
1. Incidence
2. Mortality
- 1-3.5/100,000
- 1% mortality rate
Mast cell tryptase levels 1-2 hours after onset of symptoms.
Risk of dural puncture headache following spinal anaesthetic?
1/500
Risk of temporary nerve damage following epidural anaesthesia?
1/1000
Risk of significant hypotension following epidural?
1/50
Risk of epidural providing inadequate pain relief in labour ?
Risk of epidural providing inadequate pain relief for caesarean section necessitating GA?
- 1/8 ineffective pain relief in labour
- 1/20 inadequate analgesia for C/S
Risk of dural puncture headache?
1. Epidural
2. Spinal
- 1/100 epidural
- 1/500 spinal
Risk of nerve damage (numb patch on leg or foot, or weak leg) following epidural/spinal.
- Temporary
- Permanent
- 1/1000 temporary
- 1/13000 permanent
Risk of:
1. Epidural abscess
2. Epidural haematoma
- Epidural abscess: 1/50,000
- Epidural haematoma: 1/170,000
IUD - Mife/Miso regime
Mifepristone 200mg followed 24-48hrs later by:
- 100mcg Miso 6 hourly before 26+6
- 25-50mcg 4 Miso 4 hourly at 27+0 or more, up to 24 hours
Risk of haemorrhage > 500ml with:
- Active management of 3rd stage?
- Physiological 3rd stage?
- 68/1000 with active management
- 188/1000 with physiological 3rd stage
Risk of haemorrhage > 1000ml
- Active management
- Physiological management
- 13/1000 active management
- 29/1000 physiological management
Need for blood transfusion:
- Active management 3rd stage
- Physiological management
Doubles!
- 13/1000
- 35/1000
Need for further uterotonics in 3rd stage:
- Active Management
- Physiological 3rd stage
- Active mgmt: 47/1000
- Physiological: 247/1000
3rd stage management- what were similar outcomes for both active and physiological management ?
- Retained placenta > 1hr or need for MROP
- Antibiotics for bleeding
- Satisfied with 3rd stage management
- Felt in control during labour
Nausea and vomiting in 3rd stage with:
- Active management
- Physiological management
- 100/1000
- 50/1000
Management of 3rd stage - risk of PP anaemia Hb < 90.
- Active management
- Physiological management
- 30/1000
- 60/1000
When should PET bloods be re checked after delivery for women with PET?
48-72 hrs
Do not repeat again if results are normal.
Thrombophilias and risk of PET
- Hyperhomocystinaemia
- Anticardiolipin antibodies and prothrombin heterozygosity
- Methylenetetrahydrofolate reductase gene mutation (MTHFR)
(Antithrombin III, Protein S and Protein C deficiencies, lupus anticoagulants are not associated with PET).
IVF and first trimester screening - discuss.
- PAPP-A
- HCG
- MSuE3 (maternal serum conjugated estradiol)
- Falsely low PAPP-A
- Elevated free HCG leading to false Pos Downs Syndrome screening results
- MSuE3 levels are lower
- in IVF pregnancies, the rate of false positive results in 2x as high as in normal controls in the mid trimester.
- PAPP-A was significantly lower in IVF pregnancies compared to spontaneously conceived pregnancies.
- ICSI was associated with a significantly decreased PAPP-A and an increased false positive rate.
IVF pregnancies have significantly lower PAPP-A levels supporting the need to appropriately adjust the cFTS algorithm for IVF conceptions.
- Maternal serum levels of free HCG are elevated in IVF pregnancies causing a high false positive rate on screening for DS.
- MSuE3 levels are lower in IVF pregnancies.
When compared to euploid pregnancies at 11-13 weeks, how are maternal PAPP-A levels affected with Down Syndrome?
Reduced by 50%!
Free HCG is about twice as high.
T13 is associated with what anomalies?
- Holprosencephaly
- Micro-Opthalmia
- Anopthalmia or cyclopia
- Cleft lip and palate
- Clenched fist
- Single palmar crease/scalp defects
- Post axial (little finger side) polydactyly
- Cardiac defects (VSD, PDA, dextrocardia)
- Abnormal genitalia
- Renal defects
- 10% survive beyond the first year; severe developmental delay
Carrier rate for CF in general population?
1/20 (Caucasian, no FHx)
What time frame will karyotype results be available for:
1. CVS
2. Amnio
- 48-72h from fetal blood and chorionic villi
- 2-3 weeks for Amniotic fluid
For karyotoype from maternal blood cell division must be..
Arrested in Metaphase by the addiction of colchicine which prevents spindle formation.
Choroid plexus cysts are associated with?
Increased risk of T18.
Usually resolve by 22-26/40.
Hyperechogenic bowel is associated with ?
- CF
- Meconium ileus
- T21
- CMV infection
- IUGR
- Intra uterine death
‘Subjective assessment. Diagnosis made when the echogenicity of fetal bowel is similar to or greater than that of surrounding bone,’
Significance of Cardiac echogenic foci?
Most resolve spontaneously.
Karyotype NOT indicated for isolated cardiac echogenic foci.
Definition and significance of Pelvicalyceal dilatation?
- AP diameter of the renal pelvis >4mm before 33/40 and >7mm thereafter.
- Association with aneuploidy very small and karyotype not indicated.
- Postnatal urological follow up (renal scan 1 week of age + prophylactic Abx)
Downs Syndrome;
1. Chromosomal pattern?
2. Incidence
- a) 95% due to trisomy 21
b) 4% due to translocation of chromosome 21
c) 1% mosaic
Extra chromosome 21 of maternal origin in 90% of cases - non dysjunction in first meiotic division.
- Incidence: 1/700 live births
Downs Syndrome structural anomalies?
55% have structural anomaly.
- AV canal defects
- GI - duodenal atresia
- Urinary tract
- Limb defects
- Congenital cataract
Edwards Syndrome features:
- Early onset IUGR
- Rocker bottom feet
- Clenched fists
- Overlapping fingers
- Choroid plexus cysts
- 2 vessel cord
- Increased NT
- Oligo or Poly
Associated with a low:
1. Maternal AFP
2. Maternal unconjugated estradiol
3. Maternal free HCG
Edwards Syndrome Incidence?
1/8000 live births
95% spontaneously miscarry
10% live births survive first year with profound developmental delay
Fragile X syndrome
1. Inheritance pattern
2. Features
- X linked dominant
Fragile site at Xq27 - Enlarged testes
Degree of learning disability is present in 20-30% of carrier females.
Turners Syndrome;
1. Incidence
2. Inheritance
3. Ultrasound features
45XO
- 1/2000 live born female infants
- In patients with a single X chromosome, the chromosome is of maternal origin in 2/3 cases
- Associated with:
- increased NT
- coarctation of aorta
- ASD
- cystic hygroma
- fetal hydrops
NIPT - risk of unsuccessful test?
5-10%
1/10 - 1/20
Means no fetal DNA obtained.
Women should be offered a repeat test free of charge.
NIPT:
1. High risk result
2. Low risk result
- 1/2
- < 1/10,000
Prader Willi Syndrome:
1. Incidence
2. Characterised by
- Complex genetic condition presenting in infancy and affecting 1/10,000 to 1/30,000 people
- Characterised by:
a) Hypotonia
b) Feeding difficulties
c) Poor growth with short stature
d) Delayed development with mild to mod learning disability
e) Insatiable appetite - obesity + T2DM
f) Sleep abnormalities
g) Narrow forehead, almond shaped eyes, triangular mouth
h) fair skin and light coloured hair
I) underdeveloped genitals with delayed or incomplete puberty/infertility
Incidence of Downs Syndrome
1. Age < 30
2. Age 35
3. Age 40
4. Age 45
- < 1/1000
- 1/400
- 1/105
- Age 44: 1/35, Age 46: 1/20
Combined Test monochorionic twins:
1. Gestation
2. Sensitivity
3. False Post Rate - singleton, twin
- 11+0 - 13+6 (CRL 45-84mm)
- Sensitivity 90%
- False positive rate - up to 10% (monochorionic twins)
- FPR singleton 2.5%
- FPR DCDA 5%
From what gestation can NIPT be performed?
10/40
Integrated Test + Serum Integrated Test
- What is tested?
- Detection rate and false positive rate?
- Integrated Test
NT and PAPP-A at 10/40 + AFP + free B HCG + uE3 + inhibin A at 14-20/40
Most effective screening test
Detection rate: 85%
FPR: 1.2%
- Serum Integrated Test
Integrated test without NT
Second most effective test
Detection rate: 85%
FPR: 2.7%